An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients.

Clinical Drug Investigation
Mehmet A ErsoyHayriye Elbi

Abstract

Depression is quite common among cancer patients. It has yet to be determined which antidepressant is the most effective in cancer patients with depression. The present study included 21 consecutive depressed oncology patients of whom 19 were followed up for 6 months. All patients initially received mirtazapine 15 mg/day and the dose was increased in the absence of significant treatment response and adverse effects. Depressive symptoms diminished at the end of month 1 and this improvement was maintained for the remaining 23 weeks of the study. Mean 17-item Hamilton Rating Scale for Depression (HAM-D-17) scores fell significantly from 21.4 +/- 4.9 at baseline to 6.5 +/- 3.2 at the end of the first month of treatment (p < 0.001). Among the 19 patients who were followed up, five reported at least one adverse effect during treatment; however, the vast majority of these adverse effects were described as mild to moderate. This prospective, open-label study provides preliminary evidence regarding the efficacy, safety and tolerability of mirtazapine treatment in cancer patients with depression. Relatively low doses of mirtazapine appeared to be safe and effective for treating cancer patients undergoing radiotherapy and/or chemotherapy,...Continue Reading

References

Dec 19, 1994·The American Journal of Medicine·C L DeVane
Oct 1, 1996·The British Journal of Psychiatry : the Journal of Mental Science·K van Heeringen, M Zivkov
Nov 14, 1997·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·S KasperR Wolf
Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J Savard, C M Morin
Aug 11, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A F Angelino, G J Treisman
Oct 5, 2001·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·R E Kast
May 15, 2002·Journal of Pain and Symptom Management·Dale E TheobaldSteven D Passik
Jul 21, 2004·Journal of the National Cancer Institute. Monographs·William F Pirl
Jun 1, 2005·The Lancet Oncology·Mukaila A Raji
Mar 30, 2006·The Annals of Pharmacotherapy·Sanjeev RanjanArun Gupta
Apr 25, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Chi-Un Pae
Jul 28, 2006·CNS Spectrums·Glen L Stimmel, Mary A Gutierrez
Jan 2, 2007·The Journal of Clinical Psychiatry·Alexander BrunnauerHans-Jürgen Möller
Mar 3, 2007·Journal of Psychopharmacology·Noel HannanDavid Meagher
Mar 16, 2007·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·W Stephen WaringD Nicholas Bateman
Mar 27, 2007·Pharmacotherapy·Cynthia M Way
Apr 25, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Cornelius SchüleRainer Rupprecht
Jul 12, 2007·The Annals of Pharmacotherapy·Mukaila A RajiAvi B Markowitz

❮ Previous
Next ❯

Citations

Jan 3, 2013·Psychiatry and Clinical Neurosciences·Mustafa GulecHalis Suleyman
Jan 18, 2014·Journal of Palliative Medicine·Ryan S RaddinStephen A Bernard
Feb 14, 2016·Acta Anaesthesiologica Taiwanica : Official Journal of the Taiwan Society of Anesthesiologists·Wei-Han ChouWei-Zen Sun
Jun 8, 2011·Expert Opinion on Pharmacotherapy·Sophiya Benjamin, P Murali Doraiswamy
Nov 28, 2014·Clinical Journal of Oncology Nursing·Caryl D FulcherTammie L Sherner
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Madeline LiGary Rodin
Dec 21, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Guillaume EconomosIrene J Higginson
Jul 6, 2021·Current Opinion in Psychiatry·Aliza A Panjwani, Madeline Li
Apr 15, 2009·Current Opinion in Psychiatry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.